Chenguang Biotech Group, a leading player in the biotechnology industry, is headquartered in China (CN) and operates extensively across various regions. Founded in 1992, the company has established itself as a pioneer in the development and production of high-quality biopharmaceuticals and agricultural products. Chenguang Biotech Group's core offerings include amino acids, organic acids, and other fermentation-derived products, which are distinguished by their purity and sustainability. The company has achieved significant milestones, including advancements in fermentation technology that enhance product efficacy. With a strong market position, Chenguang Biotech Group is recognised for its commitment to innovation and quality, making it a trusted partner in both the pharmaceutical and agricultural sectors. Its dedication to research and development continues to drive its success in the global market.
How does CHENGUANG BIOTECH GROUP's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Education Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
CHENGUANG BIOTECH GROUP's score of 22 is lower than 78% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Chenguang Biotech Group, headquartered in China (CN), currently does not report any specific carbon emissions data, as there are no available figures for emissions in kg CO2e. Additionally, the company has not established any documented reduction targets or climate pledges, indicating a lack of formal commitments towards carbon neutrality or emissions reduction initiatives. As of now, Chenguang Biotech Group does not inherit emissions data from any parent or related organizations, and there are no cascading targets from entities such as the Science Based Targets initiative (SBTi) or other climate-related frameworks. This absence of data and commitments suggests that the company may still be in the early stages of developing a comprehensive climate strategy. In the context of the biotechnology industry, it is increasingly important for companies to adopt transparent climate commitments and set measurable targets to align with global sustainability goals. Without specific emissions data or reduction initiatives, Chenguang Biotech Group's climate impact remains unclear, highlighting an opportunity for the company to enhance its environmental accountability and contribute to broader climate action efforts.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
CHENGUANG BIOTECH GROUP is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.